Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX).
Van Den Boom W, Quiroga MDM, O'Keefe D, Kumar D, Hill PL, Scott N, Agius PA, Higgs P, Kerr T, Maher L, Hickman M, Stoové M, Dietze P
Cost-effectiveness of antenatal corticosteroids and tocolytic agents in the management of preterm birth: A systematic review.
Sebastian E, Bykersma C, Eggleston A, Eddy KE, Chim ST, Zahroh RI, Scott N, Chou D, Oladapo OT, Vogel JP
The impact of three progressively introduced interventions on second wave daily COVID-19 case numbers in Melbourne, Australia.
Saul A, Scott N, Spelman T, Crabb BS, Hellard M
COVID-19
Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling study.
Seaman CP, Mvundura M, Frivold C, Morgan C, Jarrahian C, Howell J, Hellard M, Scott N
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.
Szanyi J, Wilson T, Scott N, Blakely T
COVID-19
Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020.
Wilkinson AL, van Santen DK, Traeger MW, Sacks-Davis R, Asselin J, Scott N, Harney BL, Doyle JS, El-Hayek C, Howell J, Bramwell F, McManus H, Donovan B, Stoové M, Hellard M, Pedrana A